News

The IgA Nephropathy drugs market is set for 18.1% CAGR growth, led by biologics, FDA approvals, and major pharma R&D efforts ...
AACE released clinical guidelines on the diagnosis, management, and surveillance of tumors related to multiple endocrine ...
Popular herbs and supplements for high blood pressure include teas, omega-3s, and garlic. Here’s how to lower blood pressure ...
LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- What Is The Projected Market Size Of Renin-Angiotensin-System RAS-Acting Agents Market? According to recent data, the ...
Discover 7 treatments for ischemic heart disease that are saving lives. From cutting-edge medications to advanced procedures ...
DZD8586 demonstrated significant anti-tumor efficacy in heavily pretreated chronic lymphocytic leukemia/small lymphocytic ...
Skye Bioscience has partnered with Arecor Therapeutics to develop a higher formulation of the former’s obesity candidate ...
Many people diagnosed with hypertension are prescribed angiotensin-converting enzyme inhibitors—better known as ACE-1 inhibitors (ACEIs)—and/or angiotensin receptor blockers (ARBs), which act ...
Participants were adults diagnosed with sarcoidosis who were prescribed ACE inhibitors or ARBs at least 1 day after their diagnosis. The primary outcome was the 5-year mortality rate after ...
AKT1 E17K mutation is a clinically validated oncogene that impacts greater than 40,000 cancer patients per year in the United States, with the highest prevalence in breast, endometrial, and prostate ...
High blood pressure accounts for about 1 in 5 cases of AFib ... angiotensin-converting enzyme inhibitors, known as ACE inhibitors, and angiotensin-receptor blockers (ARBs), can have protective ...